Rhinitis symptoms caused by grass pollen are associated with elevated basophile allergen sensitivity and a larger grass-specific immunoglobulin E fraction

Clinical and Experimental Allergy

Volumn 42, Issue 1, 2012, Pages 49-57

  Zidarn, M ^a   Kosnik M ^a   Silar M ^a   Grahek, A ^a   Korosec P ^a  

^a UNIVERSITY CLINIC OF RESPIRATORY AND ALLERGIC DISEASES   (Slovenia)

Author keywords

Allergic rhinitis; Basophil activation; CD63; Grass pollen; IgE fraction; Symptom scores

Indexed keywords

CD63 ANTIGEN; IMMUNOGLOBULIN E ANTIBODY; POLLEN ANTIGEN;

ADULT; ALLERGENICITY; ALLERGIC RHINITIS; ARTICLE; BASOPHIL; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GRASS POLLEN; HUMAN; HUMORAL IMMUNITY; MALE; NOSE PROVOCATION TEST; PHLEUM PRATENSE; POLLEN ALLERGY; POLLINATION; PRIORITY JOURNAL; SENSITIZATION; SKIN TEST; WINTER;

ADULT; ALLERGENS; BASOPHILS; FEMALE; HUMANS; IMMUNOGLOBULIN E; MALE; MIDDLE AGED; NASAL PROVOCATION TESTS; PHLEUM; PLANT PROTEINS; POLLEN; RHINITIS, ALLERGIC, SEASONAL; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84555187023     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2011.03838.x     Document Type: Article

References (30)

1. Frew AJ, Kay AB. Principles and practise of diagnosis and treatment of allergic disease. In:Kay AB, Kaplan A, Bousquet J, Holt P, eds. Allergy and allergic diseases. 2nd Edn. Chichester: Wiley-Blackwell, 2008:1321-34.
2. Nielsen NH, Dirksen A, Madsen F. Can subjects with a positive allergen skin test be selected by a short questionnaire? The Glostrup Allergy Study, Denmark. Allergy 1993; 48:319-26.
3. Bousquet J, Anto JM, Bachert C, Bousquet PJ, Colombo P, Crameri R et al. Factors responsible for differences between asymptomatic subjects and patients presenting an IgE sensitization to allergens A GA2LEN project. Allergy 2006; 61:671-80.
4. Ebo DG, Hagendorens MM, Bridts CH, De Clerck LS, Stevens WJ. Sensitization to cross-reactive carbohydrate determinants and the ubiquitous protein profilin: mimickers of allergy. Clin Exp Allergy 2004; 34:137-44.
5. Kazemi-Shirazi L, Niederberger V, Linhart B, Lidholm J, Kraft D, Valenta R. Recombinant marker allergens: diagnostic gate-keepers for the treatment of allergy. Int Arch Allergy Immunol 2002; 127:259-68.
6. Vrtala S, Susani M, Sperr WR, Valent P, Laffer S, Dolecek C et al. Immunologic characterization of purifed recombinant timothy grass pllen (Phleum pretense) allergens (phl p1, phl p2, phl p5). J Allergy Clin Immunol 1996; 97:781-7.
7. Twardosz-Kropfmüller A, Singh MB, Niederberger V et al. Association of allergic patients' phenotypes with IgE reactivity to recombinant pollen marker allergens. Allergy 2010; 65:296-303.
8. Mari A. Skin test with a timothy grass (Phleum pratense) pollen extract vs. IgE to a timothy extract vs. IgE to rPhl p 1, rPhl p 2, nPhl p 4, rPhl p 5, rPhl p 6, rPhl p 7, rPhl p 11, and rPhl p 12: epidemiological and diagnostic data. Clin Exp Allergy 2003; 33:43-51.
9. Movérare R, Petays T, Vartiainen E, Haahtela T. IgE reactivity pattern to timothy and birch pollen allergens in Finnish and Russian Karelia. Int Arch Allergy Immunol 2005; 136:33-8.
10. Bodtger U, Poulsen LK, Linneberg A. Rhinitis symptoms and IgE sensitization as a risk factors for development of later allergic rhinitis in adults. Allergy 2006; 61:712-6.
11. MacGlashan DW Jr. Releasability of human basophils: cellular sensitivity and maximal histamine release are independent variables. J Allergy Clin Immunol 1993; 91:605-15.
12. Nopp A, Cardell LO, Johansson SG, Oman H. CD-sens: a biological measure of immunological changes stimulated by ASIT. Allergy 2009; 64:811-4.
13. Lalek N, Kosnik M, Silar M, Korosec P. Immunoglobulin G-dependent changes in basophil allergen threshold sensitivity during birch pollen immunotherapy. Clin Exp Allergy 2010; 40:1186-93.
14. Melillo G, Boninni S, Davies RJ, de Monchy JG, Frølund L, Pelikan Z. EAACI provocation tests with allergens. Report prepared by the European Academy of Allergology and Clinical Immunology Subcommittee on provocation tests with allergens. Allergy 1997: 52(Suppl. 35):1-35.
15. Bousquet J, Lebel B, Dhivert H, Bataille Y, Martinot B, Michel FB. Nasal challenge with pollen grains, skin-prick tests and specific IgE in patients with grass pollen allergy. Clin Allergy 1987; 17:529-36.
16. Lebel B, Bousquet J, Morel A, Chanal I, Godard P, Michel FB. Correlation between symptoms and threshold for release of mediators in nasal secretions during nasal challenge with grass-pollen grains. J Allergy Clin Immunol 1988; 82:869-77.
17. Johansson SG, Nopp A, Oman H et al. The size of the disease relevant IgE antibody fraction in relation to 'total-IgE' predicts the efficacy of anti-IgE (Xolair) treatment. Allergy 2009; 64:1472-7.
18. Košnik M, Šilar M, Bajrovič N, Mušič E, Korošec P. High sensitivity of basophils predicts side-effects in venom immunotherapy. Allergy 2005; 60:1401-6.
19. Nopp A, Johansson SG, Ankerst J et al. Basophil allergen threshold sensitivity: a useful approach to anti-IgE treatment efficacy evaluation. Allergy 2006; 61:298-302.
20. Devillier P, Le Gall M, Horak F. The allergen challenge chamber: a valuable tool for optimizing the clinical development of pollen immunotherapy. Allergy 2011; 66:163-9.
21. Johansson SGO, Nopp A, van Hage M, Olofsson N, Lundahl J, Wehlin L et al. Passive IgE-sensitization by blood transfusion. Allergy 2005; 60:1192-9.
22. Zidarn M, Silar M, Vegnuti M, Korosec P, Kosnik M. The specificity of tests for antibeta-lactam IgE antibodies declines progressively with increase of total serum IgE. Wien Klin Wochenschr 2009; 121:353-6.
23. Laffer S, Spitzauer S, Susani M et al. Comparison of recombinant timothy grass pollen allergens with natural extract for diagnosis of grass pollen allergy in different populations. J Allergy Clin Immunol 1996; 98:652-8.
24. KleinJan A, McEuen AR, Dijkstra MD, Buckley MG, Walls AF, Fokkens WJ. Basophil and eosinophil accumulation and mast cell degranulation in the nasal mucosa of patients with hay fever after local allergen provocation. J Allergy Clin Immunol 2000; 106:677-86.
25. Muller UR. Insect sting allergy. Stuttgart, New York: Gustav Fischer Verlag, 1990.
26. Sturm GJ, Heinemann A, Schuster C et al. Influence of total IgE levels on the severity of sting reactions in Hymenoptera venom allergy. Allergy 2007; 62:884-9.
27. Perry TT, Matsui EC, Kay Conover-Walker M, Wood RA. The relationship of allergen-specific IgE levels and oral food challenge outcome. J Allergy Clin Immunol 2004; 114:144-9.
28. Pastorello EA, Incorvaia C, Ortolani C et al. Studies on the relationship between the level of specific IgE antibodies and the clinical expression of allergy: I. Definition of levels distinguishing patients with symptomatic from patients with asymptomatic allergy to common aeroallergens. J Allergy Clin Immunol 1995; 96:580-7.
29. Bødtger U, Poulsen LK, Jacobi HH, Malling HJ. The safety and efficacy of subcutaneous birch pollen immunotherapy-a one-year randomised, double-blind, placebo-controlled study. Allergy 2002; 57:297-305.
30. Graif Y, Goldberg A, Tamir R, Vigiser D, Melamed S. Skin test results and selfreported symptom severity in allergic rhinitis: the role of psychological factors. Clin Exp Allergy 2006; 36:1532-7.